Descriptive Comparison of the Efficacy and Safety of OnabotulinumtoxinA for Headache Prophylaxis in Adult Chronic Migraine Patients from Two Long-term, Multicenter Studies: COMPEL vs. PREEMPT

Aurora S.; Stark R.; Reppine A.; Adams Manack A.; Blumenfeld A.

首页> 外文期刊>Headache >Descriptive Comparison of the Efficacy and Safety of OnabotulinumtoxinA for Headache Prophylaxis in Adult Chronic Migraine Patients from Two Long-term, Multicenter Studies: COMPEL vs. PREEMPT

【24h】

Descriptive Comparison of the Efficacy and Safety of OnabotulinumtoxinA for Headache Prophylaxis in Adult Chronic Migraine Patients from Two Long-term, Multicenter Studies: COMPEL vs. PREEMPT

机译：来自两项长期，多中心研究的成人慢性偏头痛患者中预防性嗜肺气单胞菌毒素A疗效和安全性的描述性比较：COMPEL vs. PREEMPT

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Headache》 |2015年第s3期|共1页
作者
Aurora S.; Stark R.; Reppine A.; Adams Manack A.; Blumenfeld A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类诊断学;
关键词

相似文献

外文文献

1. Descriptive Comparison of the Efficacy and Safety of OnabotulinumtoxinA for Headache Prophylaxis in Adult Chronic Migraine Patients from Two Long-term, Multicenter Studies: COMPEL vs. PREEMPT [J] . Aurora S., Stark R., Reppine A., Headache . 2015,第S3期

机译：来自两项长期，多中心研究的成人慢性偏头痛患者中预防性嗜肺气单胞菌毒素A疗效和安全性的描述性比较：COMPEL vs. PREEMPT
2. Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine [J] . Andrew M Blumenfeld, Sheena K Aurora, Karen Laranjo, BMC Neurology . 2015,第1期

机译：慢性偏头痛中的未满足临床需求：对慢性偏头痛进行高分性疗效，安全性和耐药性的长期疗效，安全性和耐受性的研究和设计的理由，具有慢性偏头痛的成人头痛预防
3. Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety [J] . Guy P Boudreau, Brian M Grosberg, Peter J McAllister, International Journal of General Medicine . 2015,第4期

机译：慢性偏头痛和合并症抑郁患者的预防性肉毒杆菌毒素A：一项开放性，多中心，前瞻性研究，研究头痛相关的残疾，抑郁和焦虑的功效，安全性和影响
4. Cortical Stimulation for the Rehabilitation of Patients with Hemiparetic Stroke: A Multicenter Feasibility Study of Safety and Efficacy [C] . R. Levy, S. Ruland, M. Weinand, World Society for Stereotactic and Functional Neurosurgery . 2005

机译：皮质刺激对血珠中风患者的康复：一种安全性和疗效的多中心可行性研究
5. Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL an open-label multicenter study of the long-term efficacy safety and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine [O] . Andrew M. Blumenfeld, Sheena K. Aurora, Karen Laranjo, 2015

机译：慢性偏头痛的临床需求未得到满足：研究和设计COMPEL的原理这是一种开放性多中心研究证明肉毒杆菌毒素A可以预防成人慢性偏头痛的长期疗效安全性和耐受性
6. Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine [O] . Andrew M. Blumenfeld, Sheena K. Aurora, Karen Laranjo, 2015

机译：慢性偏头痛的临床需求未得到满足：研究和设计COMPEL的原理，这是一种开放性，多中心研究，证明肉毒杆菌毒素A可以预防成人慢性偏头痛的长期疗效，安全性和耐受性
7. Double Blind, Randomized Study of Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT A) versus Oral Oxybutynin in SCI Patients with NDO (11 09 10 04). [R] . Smith, C. P. 2017

机译：双盲，随机研究Onabotulinumtoxina（OnaBoNT a）与口服奥昔布宁在NDO患者中的安全性和有效性（11 09 10 04）。

Descriptive Comparison of the Efficacy and Safety of OnabotulinumtoxinA for Headache Prophylaxis in Adult Chronic Migraine Patients from Two Long-term, Multicenter Studies: COMPEL vs. PREEMPT

著录项

相似文献

相关主题

期刊订阅